Roche faricimab nAMD Symposium: Advancing the management of nAMD via Ang-2/VEGF-A dual inhibition Lunch box served 12:00-12:15
Chair:
Ângela Carneiro,Portugal
12:15
Welcome and opening remarks Ângela Carneiro, Portugal
12:20
Evidence for Ang-2/VEGF-A inhibition in nAMD: Preclinical and Phase 3 data Rufino Silva, Portugal
12:35
Real world clinical case discussions
James Talks, UK; David Almeida, USA
Audience Q&A with the panel
13:10
Closing remarks
Ângela Carneiro, Portugal
Add Your Heading Text Here
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok